Adjuvant Therapy for Stage II Colon Cancer: Prognostic and Predictive Markers

By Vicuna Brian   Benson Al B.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 9, 2007-10 ,pp. : 927-936

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

By Mougalian Sarah S.   Soulos Pamela R.   Killelea Brigid K.   Lannin Donald R.   Abu-Khalaf Maysa M.   DiGiovanna Michael P.   Sanft Tara B.   Pusztai Lajos   Gross Cary P.   Chagpar Anees B.  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2544-2552

Blackwell Publishing

Access to resources Recommend Favorite

Serum Her-2/neu and Survivin Levels and Their Relationship to Histological Parameters in Early-stage Breast Cancer

By Goksel G   Taneli F   Uslu R   Ulman C   Dinc G   Coskun T   Kandiloglu AR  

The Journal of International Medical Research, Vol. 35, Iss. 2, 2007-03 ,pp. : 165-172

Field House Publishing

Access to resources Recommend Favorite

Tumor endothelial markers as a target in cancer

By Ribatti Domenico   Ranieri Girolamo   Basile Antonio   Azzariti Amalia   Paradiso Angelo   Vacca Angelo  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1215-1225

Informa Healthcare

Access to resources Recommend Favorite

A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

By Sunpaweravong Patrapim   Magree Lyn   Rabinovitch Rachel   Bunn Paul   Kelly Karen  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 213-221

Springer Publishing Company

Access to resources Recommend Favorite